Als Amyotrophic Lateral Sclerosis Clinical Trials

ReadTheTrial indexes 2 studies for Als Amyotrophic Lateral Sclerosis. The most common development stage is N/A (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Als Amyotrophic Lateral Sclerosis.

Pipeline by Phase

PhaseTrialsDistribution
N/A 2
100%

Trial Status Breakdown

Trials for Als Amyotrophic Lateral Sclerosis

Characterization of Platelet Molecular Profiles in ALS for the Identification of Specific Diagnostic Biomarkers - A Pilot Study

NCT07479017 · NOT YET RECRUITING · N/A

Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches

NCT06856850 · RECRUITING · N/A

Frequently Asked Questions

What clinical trials are available for Als Amyotrophic Lateral Sclerosis?

There are 2 clinical trials listed for Als Amyotrophic Lateral Sclerosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Als Amyotrophic Lateral Sclerosis trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Als Amyotrophic Lateral Sclerosis trials in?

Current Als Amyotrophic Lateral Sclerosis trials are distributed across: N/A (2).

Find More Trials